THE QUALITY EVALUATION OF THE MRC5 WORKING CELL BANK USED FOR VACCINE QUALITY CONTROL
DOI:
https://doi.org/10.56086/jcvb.v6i3.268Keywords:
MRC5, Working Cell Bank, Vaccine quality controlAbstract
MRC-5 is a human diploid cell line widely used in vaccine research and quality control. This study was conducted to evaluate the quality of the MRC-5 WCB 0125 P31/NICVB Working Cell Bank in accordance with the recommendations of the World Health Organization (WHO). The Working Cell Bank at passage 31 (P31) was produced from the MRC-5 P26 seed cell stock, originating from the international reference cell line obtained from the European Collection of Authenticated Cell Cultures (ECACC). The evaluated parameters included morphological identity, sterility, inter-vial homogeneity, cell viability (averaging 1,07 x 10^6 cells/ml, viability> 80%), Mycoplasma, Mycobacterium tuberculosis, and in vitro adventitious agents. The results demonstrated that the MRC-5 WCB 0125 P31/NICVB Working Cell Bank fully met all quality requirements. The product exhibited high inter-laboratory reproducibility verified by independent parallel testing at two laboratories (NICVB and VABIOTECH), making it ready for implementation as a secondary reference standard for vaccine research and quality control.
